Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

In the year 2025, Aquestive Therapeutics had annual revenue of $44.55M, down -22.61%. Aquestive Therapeutics had revenue of $13.02M in the quarter ending December 31, 2025, with 9.67% growth.

• Revenue (ttm): $44.55M
• Revenue Growth: -22.61%
• P/S Ratio: 11.51
• Revenue / Employee: $303,027
• Employees: 147
• Market Cap: 512.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	44.55M	-13.02M	-22.61%
Dec 31, 2024	57.56M	6.98M	13.80%
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%
Dec 31, 2018	67.43M	512.00K	0.77%
Dec 31, 2017	66.92M	15.13M	29.22%
Dec 31, 2016	51.79M	49.07M	1,807.37%
Dec 31, 2006	2.72M	592.00K	27.89%
Dec 31, 2005	2.12M	-	-